Ibrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT02635074 · TERMINATED
Trial details
- NCT number
- NCT02635074
- Sponsor
- Steven E. Coutre
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-07-18
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.